Iain is the founding Chief Executive Officer of Quell Therapeutics. He has over 25 years of experience in the pharmaceutical and biotech sector. He joined Quell from Jazz Pharmaceuticals where he served on the Executive Committee and as Head of Europe and Rest of World for Jazz Pharmaceuticals plc with responsibility for ex-U.S. operations. Prior to that he served as Chief Commercial Officer of EUSA Pharma, a transatlantic specialty pharmaceutical company based in the UK which was acquired by Jazz Pharmaceuticals. He also served as Vice President and Global Business Manager for Transplantation and Immunology at Wyeth as well as general management and commercial leadership positions with increasing responsibility over thirteen years at Novartis and Roche. He holds a Bachelor of Science degree in Biochemistry from the University of London.